Status and phase
Conditions
Treatments
About
The purpose of this study is to investigate the association between UGT1A1 polymorphisms and neutropenia and diarrhea in Korean patients with advanced colorectal or gastric cancer treated with FOLFIRI regimen.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:Subjects should meet all of the following criteria to participate in the trial.
Histologically confirmed colorectal or gastric cancer patients who are chemonaive or failed to 1st line chemotherapy
Subjects who are expected to receive toxicity test at least once after FOLFIRI treatment.
Aged 18 years or older.
ECOG performance status of ≤ 2.
Anticipated life expectancy of ≥ 3 months.
Clinically acceptable function of bone marrow, kidney and liver function as below.
Subjects whose written informed consent can be obtained prior to their participation in the trial.
Exclusion Criteria: Subjects who meet any of the following criteria should not be included in the trial.
Primary purpose
Allocation
Interventional model
Masking
1,500 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal